Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF821 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
mRNA | TXNDC16 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
mRNA | ZNF709 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
mRNA | ENTPD6 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | SPRED1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
mRNA | CST3 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | RP4-635E18.9 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
mRNA | NPAS2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | ADGRE5 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | TMEFF1 | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-08 |